Cerevel Therapeutics Holdings, Inc.
Cerevel Therapeutics Holdings, Inc. (CERE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CERE · as of Jun 9, 2026
Key Statistics
Explore Cerevel Therapeutics Holdings, Inc. Data
cere stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 16 · Buy rate: 37.5%
The CERE analyst consensus is Hold, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month price target is $33.50, representing -25.49% downside from the current price of $44.96.
Competitors & Peers
cere competitorsCERE
BPMC
IMGN
ISEE
MRTX
OSHStock Performance
Full HistoryAbout Cerevel Therapeutics Holdings, Inc.
Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing treatments for a range of neuroscience disorders. The company boasts a robust pipeline of therape…
what is cerevel therapeutics holdings, inc. · cere stock overview · cerevel therapeutics holdings, inc. company profile · who is cerevel therapeutics holdings, inc. ceo · cere NASDAQ · cerevel therapeutics holdings, inc. headquarters · cerevel therapeutics holdings, inc. business segments
About Stock Overview & Key Data
Cerevel Therapeutics Holdings, Inc. (CERE) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 30, 2020. As of the latest trading session, CERE stock price is $44.96, with a market capitalization of $8.2B. The stock has returned +87.88% over the past 12 months and +6.52% year-to-date.
According to 16 Wall Street analysts, the consensus rating for Cerevel Therapeutics Holdings, Inc. stock is Hold, with an average 12-month price target of $33.50. In fiscal year 2023, Cerevel Therapeutics Holdings, Inc. reported revenue of — and net income of -$432.8M. For detailed data — including Cerevel Therapeutics Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cerevel Therapeutics Holdings, Inc. (CERE) stock price is $44.96. The stock is traded on NASDAQ under the ticker symbol CERE. The 52-week range is $19.59 – $44.99.